Bristol-Myers Squibb To Take Part In Credit Suisse 2016 Health Care Conference

Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Credit Suisse Annual Health Care Conference on Tuesday, November 8, 2016 in Scottsdale, Arizona. Fouad Namouni, senior vice president, Head Oncology Development, will answer questions about the company at 8 a.m. MT (10 a.m. ET).

Investors and the general public are invited to listen to a live webcast of the session at An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at or follow us on LinkedInTwitter, YouTube and Facebook.


View source version on
Copyright Business Wire 2010

If you liked this article you might like

Bristol-Myers Squibb Stock Still a Beast?

There Are Good Opportunities in Stock Picking

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Achillion Shares Are Plunging on Termination of Hepatitis C Pact